Susan Coughlin

2.9k total citations · 1 hit paper
21 papers, 2.1k citations indexed

About

Susan Coughlin is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Susan Coughlin has authored 21 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Susan Coughlin's work include Cancer therapeutics and mechanisms (11 papers), Lung Cancer Research Studies (5 papers) and Neutropenia and Cancer Infections (4 papers). Susan Coughlin is often cited by papers focused on Cancer therapeutics and mechanisms (11 papers), Lung Cancer Research Studies (5 papers) and Neutropenia and Cancer Infections (4 papers). Susan Coughlin collaborates with scholars based in United States, Australia and Spain. Susan Coughlin's co-authors include Nathan Levitan, Mark Allen O’Rourke, Ronald L. Burkes, Janet Dancey, J. Bérille, Rodryg Ramlau, Richard J. Gralla, Frances A. Shepherd, K. Mattson and Laurent Gressot and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Analytical Biochemistry.

In The Last Decade

Susan Coughlin

21 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

2000 1.7k citations Frances A. Shepherd, Janet Dancey et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Susan Coughlin

Since Specialization

Citations

This map shows the geographic impact of Susan Coughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Coughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Coughlin more than expected).

Fields of papers citing papers by Susan Coughlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Coughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Coughlin. The network helps show where Susan Coughlin may publish in the future.

Co-authorship network of co-authors of Susan Coughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Coughlin. A scholar is included among the top collaborators of Susan Coughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Coughlin. Susan Coughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy 2023 ·Journal of Clinical Oncology ·Frances A. Shepherd, Janet Dancey, Rodryg Ramlau, K. Mattson, Richard J. Gralla, Mark Allen O’Rourke, Nathan Levitan, Laurent Gressot, Mark Vincent, Ronald L. Burkes, Susan Coughlin, Yong Kim, J. Bérille	7
2	Outcome of second-line treatment (2L Tx) following nab-paclitaxel (nab-P) + gemcitabine (G) or G alone for metastatic pancreatic cancer (MPC). 2016 ·Journal of Clinical Oncology ·David Goldstein, E. Gabriela Chiorean, Josep Tabernero, Robert H. El-Maraghi, Wen Wee, Michele Reni, Marion Harris, Robert C. Whorf, Susan Coughlin, (unknown), Victoria Manax, Brian Lu, Alfredo Romano, Daniel D. Von Hoff	2
3	Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study 2007 ·Developmental Medicine & Child Neurology ·Horacio Plotkin, Susan Coughlin, (unknown), (unknown), Matías Bruzoni, Gary Lerner	8
4	Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study 2006 ·Developmental Medicine & Child Neurology ·Horacio Plotkin, Susan Coughlin, (unknown), (unknown), Matías Bruzoni, Gary Lerner	46
5	Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy breakdown → 2000 ·Journal of Clinical Oncology ·Frances A. Shepherd, Janet Dancey, Rodryg Ramlau, K. Mattson, Richard J. Gralla, Mark Allen O’Rourke, Nathan Levitan, Laurent Gressot, Mark Vincent, Ronald L. Burkes, Susan Coughlin, Yong Kim, J. Bérille	1717
6	Synthesis and Antitumor Activity of 4-Aminomethylthioxanthenone and 5-Aminomethylbenzothiopyranoindazole Derivatives 1998 ·Journal of Medicinal Chemistry ·Robert B. Perni, Mark P. Wentland, Jianhua Huang, (unknown), Suzanne C. Aldous, (unknown), (unknown), R. Robinson, Thomas H. Corbett, Julie Jones, Kenneth C. Mattes, James Rake, Susan Coughlin	15
7	Cyclic variations of SR 233377 (WIN 33377) and effects on antitumor activity 1996 ·Bioorganic & Medicinal Chemistry Letters ·Mark P. Wentland, Robert B. Perni, Jianhua Huang, (unknown), Suzanne C. Aldous, (unknown), (unknown), R. Robinson, Thomas H. Corbett, Julie Jones, James Rake, Susan Coughlin	13
8	Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyridol [1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161) 1995 ·Biochemical Pharmacology ·Susan Coughlin, (unknown), R. Robinson, (unknown), Mark P. Wentland, Thomas H. Corbett, William R. Waud, Leonard A. Zwelling, Elizabeth Altschuler, Elise S. Bales, James Rake	32
9	3-benzyl-quinolones: Novel, potent inhibitors of mammalian topoisomerase II 1995 ·Bioorganic & Medicinal Chemistry Letters ·Michael A. Eissenstat, Gee‐Hong Kuo, John D. Weaver, Mark P. Wentland, R. Robinson, (unknown), (unknown), Thomas H. Corbett, Susan Coughlin	13
10	The antitumor activity of novel pyrazoloquinoline derivatives 1995 ·Bioorganic & Medicinal Chemistry Letters ·Mark P. Wentland, Suzanne C. Aldous, M. D. GRUETT, Robert B. Perni, (unknown), (unknown), (unknown), (unknown), R. Robinson, Thomas H. Corbett, James Rake, Susan Coughlin	30
11	Potent mammalian topoisomerase II inhibitors: 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-substituted-quinolines 1995 ·Bioorganic & Medicinal Chemistry Letters ·Gee‐Hong Kuo, Michael A. Eissenstat, Mark P. Wentland, (unknown), (unknown), (unknown), Susan Coughlin	6
12	Topical CTC-96 accelerates wart growth in rabbits infected with cottontail rabbit papillomavirus 1994 ·Antiviral Research ·Ronald S. Ostrow, Susan Coughlin, Ronald C. McGlennen, Zhanjiang Liu, Daniel Zelterman, Anthony J. Faras	7
13	ChemInform Abstract: Mammalian Topoisomerase II Inhibitory Activity of 1‐Cyclopropyl‐6,8‐ difluoro‐1,4‐dihydro‐7‐(2,6‐dimethyl‐4‐pyridinyl)‐4‐oxo‐3 ‐ quinolinecarboxylic Acid (I) and Related Derivatives. 1994 ·ChemInform ·Mark P. Wentland, George Y. Lesher, Michael Reuman, M. D. GRUETT, Baldev Singh, Suzanne C. Aldous, Peter H. Dorff, James Rake, Susan Coughlin	1
14	Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxylic acid and related derivatives 1993 ·Journal of Medicinal Chemistry ·Mark P. Wentland, George Y. Lesher, Michael Reuman, M. D. GRUETT, Baldev Singh, Suzanne C. Aldous, Peter H. Dorff, James Rake, Susan Coughlin	58
15	Isolation and Characterization of Monoclonal Antibodies to a Recombinant Human Topoisomerase II Polypeptide 1993 ·Hybridoma ·(unknown), (unknown), (unknown), Margaret Graham, (unknown), Susan Coughlin	6
16	Relationship of structure of bridged (2,6-dimethyl-4-pyridinyl)quinolones to mammalian topoisomerase II inhibition 1993 ·Bioorganic & Medicinal Chemistry Letters ·Mark P. Wentland, George Y. Lesher, Michael Reuman, (unknown), Manohar Saindane, Robert B. Perni, Michael A. Eissenstat, John D. Weaver, Baldev Singh, James Rake, Susan Coughlin	4
17	Inhibitors of DNA gyrase 1989 ·Pharmacology & Therapeutics ·Karl Drlica, Susan Coughlin	45
18	A multiprotein form of DNA polymerase alpha from HeLa cells. Resolution of its associated catalytic activities. 1986 ·Journal of Biological Chemistry ·Jamboor K. Vishwanatha, Susan Coughlin, (unknown), Earl F. Baril	102
19	5′,5‴-P¹, P⁴Diadenosine Tetraphosphate (Ap₄A): A Putative Initiator of DNA Replication 1985 ·Cancer Investigation ·Earl F. Baril, Susan Coughlin, Paul C. Zamecnik	25
20	Two-dimensional zymogram analysis of nucleases in Bacillus subtilis 1983 ·Analytical Biochemistry ·Susan Coughlin, (unknown)	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact